Compass Therapeutics, Inc. (CMPX)
1.135
0.00 (0.00%)
USD |
NASDAQ |
Sep 25, 15:48
Compass Therapeutics Cash and Short Term Investments (Quarterly) : 179.88M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 179.88M |
| March 31, 2026 | 194.69M |
| December 31, 2025 | 208.91M |
| September 30, 2025 | 219.90M |
| June 30, 2025 | 100.95M |
| March 31, 2025 | 112.64M |
| December 31, 2024 | 126.72M |
| September 30, 2024 | 135.40M |
| June 30, 2024 | 146.23M |
| March 31, 2024 | 156.26M |
| December 31, 2023 | 152.46M |
| September 30, 2023 | 163.70M |
| June 30, 2023 | 168.75M |
| March 31, 2023 | 175.17M |
| Date | Value |
|---|---|
| December 31, 2022 | 186.61M |
| September 30, 2022 | 120.60M |
| June 30, 2022 | 132.02M |
| March 31, 2022 | 136.38M |
| December 31, 2021 | 144.51M |
| September 30, 2021 | 25.51M |
| June 30, 2021 | 31.21M |
| March 31, 2021 | 39.70M |
| December 31, 2020 | 47.08M |
| September 30, 2020 | 55.52M |
| June 30, 2020 | 65.37M |
| March 31, 2020 | 17.53M |
| December 31, 2019 | 25.30M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 237.93M |
| Ardelyx, Inc. | 281.83M |
| ARS Pharmaceuticals, Inc. | 143.84M |
| Upstream Bio, Inc. | 261.31M |
| Sionna Therapeutics, Inc. | 211.03M |